Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Tests high-intensity interval training for heart and metabolic health in school children

Tests short bursts of intense exercise in school-age children at high heart disease risk.

Plain-language title generated from the registry record
Registry title: High-Intensity Interval Training(HIIT) on Cardio-metabolic Risk in School-age Children

Key facts

Where
Shanghai, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 7 and 18 years old?

Source: NCT06416488, who can take part

Where in China

  • Children's Hospital Of Fudan UniversityShanghai, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Children's Hospital of Fudan University
Trial code
NCT06416488
Record updated
16 December 2025
Original description
This study aims to evaluate the health promotion effects of high-intensity interval training (HIIT) intervention on school-age children who are at high risk for cardiovascular disease (CVD), as well as the long-term adherence and acceptability of HIIT in this population for future application.Read full original descriptionShow less

The Effect of High-Intensity Interval Training(HIIT) on Cardio-metabolic Indicators in School-age Children With High Cardiovascular Diseases Risk--a Randomised Intervention Trial

This study aims to evaluate the health promotion effects of high-intensity interval training (HIIT) intervention on school-age children who are at high risk for cardiovascular disease (CVD), as well as the long-term adherence and acceptability of HIIT in this population for future application.

Inclusion: Aged 7-18 years at baseline; At least one of the following cardio-metabolic abnormalities:; Prediabetes (Impaired fasting glucose: 5.6 ≤ fasting blood glucose level ≤ 6.9 mmol/L; or Impaired glucose tolerance: 7.8 ≤ blood glucose level after 2 hours postprandial ≤ 11.0 mmol/L); Lipid abnormalities (High-density lipoprotein cholesterol ≤ 1.04 mmol/L; or Low-density lipoprotein cholesterol ≥ 3.37 mmol/L; or Triglycerides ≥ 1.70 mmol/L, or Total cholesterol ≥ 5.18 mmol/L); Elevated blood pressure (Systolic/diastolic blood pressure consistently higher than the 90th percentile for gender, age, and height; or systolic/diastolic blood pressure ≥ 120/80 mmHg); Written consent from participants and their guardians.

Exclusion: Previously diagnosed with heart failure, severe malnutrition, immune deficiency, liver or kidney disease, cancer, or other diseases deemed unsuitable for participation; Taking weight loss drugs, or undergone weight loss surgery; Secondary obesity, such as neuropsychiatric disorders, endocrine disorders, sleep apnea syndrome, or other conditions; Unable to take interventions due to health conditions, such as joint diseases, fractures, injuries; Attending behavior-based intervention programs (exercise or diet) within a year; Regular HIIT (at least once per week); Other situations unsuitable for participation.

ClinicalTrials.gov NCT06416488